Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Higher-dose arm initiated in ongoing Phase 2 study following safety review by independent Data Monitoring Committee New Phase 2 study planned for patients who have one copy of the...
-
BOULDER, Colo., March 01, 2016 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on developing innovative solutions for people with...
-
- Phase 2 Study Enrollment Progressing - Orphan Drug and Fast Track Designations Granted for N91115 in Cystic Fibrosis BOULDER, Colo., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Nivalis Therapeutics,...
-
BOULDER, Colo., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on developing innovative solutions for people with...
-
BOULDER, Colo., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on developing innovative solutions for people with...
-
BOULDER, Colo., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis (“CF”), today...
-
BOULDER, Colo., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis (CF), today...
-
- N91115 Phase 1b Data Recently Presented at North American Cystic Fibrosis Conference - Phase 2 Study on Track to Enroll First Patient in Fourth Quarter BOULDER, Colo., Nov. 02, 2015 ...
-
- No dose limiting toxicities were observed and N91115 was well tolerated in the study- Data to be presented at the North American Cystic Fibrosis Conference BOULDER, Colo., Oct. 07, 2015 (GLOBE...
-
BOULDER, Colo., Sept. 4, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis, today announced...